Page 13 - Compugen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioPharma

StockNews.com initiated coverage on shares of Compugen (NASDAQ:CGEN – Free Report) in a report published on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Compugen Trading Down 3.8 % Compugen stock traded down $0.04 during midday trading on Thursday, reaching $1.02. 289,928 shares of the company’s stock were exchanged, compared […]

Compugen Ltd. (NASDAQ:CGEN – Get Free Report) has received an average rating of “Moderate Buy” from the five research firms that are covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average 12-month price target among brokerages […]

The next world of hybrid work is a three-part video series that examines the nature of the hybrid office, and the challenges—and advantages—associated with it. Featuring experts from Cisco Systems and Compugen and hosted by IT World Canada’s Jim Love, the series helps explore the challenges and the opportunities facing us all in the new

Compugen Ltd. (NASDAQ:CGEN) Q2 2023 Earnings Call Transcript August 7, 2023 Operator: Ladies and gentlemen, thank you for joining us today. Welcome to Compugen’s Second Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode. As a reminder, today’s call is being recorded. An audio webcast of this call will […]